Houston Methodist Hospital
T

Who is Not Optimally Benefitting From Our Stroke Therapies and What Can We Do About It?

By Houston Methodist Hospital FEATURING Thomas Kent
By Houston Methodist Hospital FEATURING Thomas Kent
104 views
May 11, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
Medical College of Georgia - Augusta University

Comprehensive Stroke Update 2024 - Kiawah Island

Thu, Jun 13, 2024
12:04
Stephen Kopecky

Role of PCSK9 Inhibitors in Diabetes

28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason
26:32
Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen
19:20
National Lipid Association

Colchicine: Now and What’s Next?

Feat. C. Ballantyne
22:14
Practical Ways to Achieve Targets in Diabetes Care

Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target

Feat. S. Nissen
21:10
National Lipid Association

Plant-based Diets for Improving Lipids

Feat. K. Williams
19:24
James Siegler

Cutting Edge Concepts in Secondary Prevention for Acute Ischemic Str…

11:26
Houston Methodist DeBakey Heart and Vascular Center

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Feat. M. Miedema
11:50
American Heart & Vascular Institute

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

Feat. M. Kittleson
29:04
15th Annual Orange County Symposium for Cardiovascular Disease Prevention

LDL-C: Earlier and Lower Is Better and Safer?

Feat. P. Rosenblit
26:13
ZINCARE

Stroke Prevention

Feat. A. E. Hillis
25:54
13th Orange County Symposium for Cardiovascular Disease Prevention

SGLT2 inhibitors and GLP-1 agonists: Why Are They Important and Whic…

Feat. Y. Handelsman
30:00
Piedmont Heart Institute

Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i

Feat. J. Burkle
33:42
University of Miami

Secondary Stroke Prevention in Atrial Fibrillation

Feat. N. Sur
62:17
HeartFlow

Chest Pain in Women: CT's role in making an accurate diagnosis

Feat. L. Shaw, M. Gulati
32:08
University of Miami

Primary Stroke Prevention

Feat. R. Sacco
24:06
Practical Ways to Achieve Targets in Diabetes Care

Prediabetes: The Prelude to Macrovascular (MI, Stroke) Complications

Feat. R. DeFronzo
62:08
University of Louisville

Update on Coronary Revascularization

Feat. S. Ghafghazi
24:45
National Lipid Association

Cardiovascular Disease in Patients with HIV

Feat. W. R. Short
18:42
Cardiometabolic Health Congress (CMHC)

ASCVD Risk Assessment and Prevention: Where Do We Stand Now?

Feat. S. Virani